Symphony Environmental Technologies FDA Approval opens wider opportunities (Interview)

Symphony Environmental Technologies plc (LON:SYM) CFO Ian Bristow joins DirectorsTalk to discuss approval from the U.S. Food & Drug Administration for its d2p antimicrobial food contact technology. Ian explains what this means for the company, the market value they are now targeting, other regions now being targeted and what else investors can look out for over the coming months.

Symphony Environmental Technologies is a world leader in the development of additives to make ordinary plastic biodegradable, and protective technologies to enhance plastic products.

Find more news, interviews, share price & company profile here for:
Symphony Environmental Technologies Plc

Share this interview

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp
Symphony Environmental Interview
Symphony Environmental Technologies FDA Approval opens wider opportunities (Interview)

Other Interviews

More News

Ask your questions

Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.   

I have questions